Accelerating Innovation: Tokyo's Deep Tech Hub
Tokyo is taking significant strides in promoting a global platform for startups by establishing a deep tech innovation hub, centered around the Tokyo Innovation Base (TIB). This initiative aims to forge connections among entrepreneurs, business companies, and investors, thereby enhancing support for startups in sectors like life sciences, AI, and robotics.
While the deep tech fields promise substantial global growth, they often require extensive research and development time before transitioning to commercialization and societal implementation. Recognizing this challenge, the Tokyo Metropolitan Government has undertaken efforts to create a specialized innovation hub tailored to deep tech startups, beginning last year. Recently, there have been notable developments regarding the establishment of a new hub in the Tama area.
Key Project Overview
The new hub will be spearheaded by Teijin Pharma Ltd., a wholly-owned subsidiary of Teijin Group, known for its long-standing commitment to healthcare-related research through various joint projects with internal and external collaborators. Their Tokyo Research Center, established in 1960 and located in Hino City, Tokyo, is set to host an incubation facility dedicated to supporting startups.
Covering a vast area of 63,000 square meters with a total floor space of 30,000 square meters, the research center will boast cutting-edge facilities. It will feature wet labs compliant with biosafety standards (BSL2/P2), which are essential for microbiological and genetic research, as well as animal experimentation areas. Additionally, the hub will include a co-working space equipped with 3D printers and other prototyping technologies tailored for healthcare-focused deep tech startups.
Teijin Pharma aims not just to provide physical space but also to cultivate an ecosystem where collaborating startups can interact with their seasoned professionals, sparking innovative ideas and breakthroughs in the healthcare sector. This immersive environment is designed to promote unmatched creativity and pave the way for novel healthcare solutions, aligning with the company's vision of solving challenges faced by patients, families, and local communities.
Teijin Pharma: Commitment to Healthcare Innovation
The vision behind Teijin Pharma emphasizes being a company that addresses the needs of vulnerable patients and their communities. By integrating medical devices with treatments for rare and serious diseases, the company strives to ensure that more individuals can access desired medical care in their familiar surroundings. At the Tokyo Research Center, Teijin Pharma is actively engaged in research and development, leveraging their expertise in drug discovery, medical technology, and engineering to create new healthcare solutions.
In collaboration with academia, startups, and major pharmaceutical firms, Teijin Pharma has successfully executed numerous joint research projects, reinforcing its role as a pivotal player in the global healthcare landscape.
For more information on this initiative, visit the official website:
Tokyo Startup and Global Financial City.
This undertaking aligns with the Tokyo Metropolitan Government's '2050 Tokyo Strategy,' particularly focusing on nurturing startups capable of operating on a global scale.